SARS-CoV-2-IN-17 structure
|
Common Name | SARS-CoV-2-IN-17 | ||
|---|---|---|---|---|
| CAS Number | 2761911-44-6 | Molecular Weight | 380.36 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C19H19F3N2O3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of SARS-CoV-2-IN-17SARS-CoV-2-IN-17 (Compound 16) is a potent SARS-CoV-2 nucleocapsid protein (NPro) inhibitor. SARS-CoV-2-IN-17 exhibits potent anti-viral activity with the EC50 of 2.18 μM. SARS-CoV-2-IN-17 binds to NPro with the low KD value of 7.82 μM, suggesting that SARS-CoV-2-IN-17 is a potent NPro ligand[1]. |
| Name | SARS-CoV-2-IN-17 |
|---|
| Description | SARS-CoV-2-IN-17 (Compound 16) is a potent SARS-CoV-2 nucleocapsid protein (NPro) inhibitor. SARS-CoV-2-IN-17 exhibits potent anti-viral activity with the EC50 of 2.18 μM. SARS-CoV-2-IN-17 binds to NPro with the low KD value of 7.82 μM, suggesting that SARS-CoV-2-IN-17 is a potent NPro ligand[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C19H19F3N2O3 |
|---|---|
| Molecular Weight | 380.36 |